NSE: MANKIND · 14 October 2026
- Mankind Pharma Limited shares declined -2.47% during the session, trading near the lower end of the day's range between 2333.40 and 2372.00 after opening at 2372.00.
- Mankind Pharma Limited submitted the scrutinizer's report of the postal ballot along with the formal voting results to the stock exchanges. This regulatory filing completes the procedural requirements associated with recent shareholder resolutions. The submission forms part of the standard corporate governance disclosure process.
- Trading volume was 0.05 times the 20-day average daily volume.
Why is Mankind Pharma share price falling on 14 October 2026?
Mankind Pharma Limited shares declined -2.47% during the session, trading near the lower end of the day's range between 2333.40 and 2372.00 after opening at 2372.00.
The broader market showed modest gains with the Nifty rising 0.13%, whereas the pharma sector faced notable pressure as reflected by the Nifty Pharma index dropping -1.43%. Mankind's decline outpaced the broader sector benchmark while extending its recent 5-day pullback to -6.38%, even as the stock retains a positive 2.66% return over the trailing 20-day period.
Recent corporate developments indicate ongoing structural changes, including the board's August decision to voluntarily liquidate its wholly owned material subsidiary Bharat Serums and Vaccines Limited for integration into the parent company. While these corporate restructuring moves and prior postal ballot updates provide operational context, no single confirmed company-specific catalyst was reported to directly trigger today's downward price action.
28,828 shares traded by 14 October 2026 · 09:45 AM IST. This compares with a 20-day average daily volume of 6.10 lakh shares (0.05 times). The five-day average daily volume was 3.67 lakh shares. Separately, the NSE report for 13 October 2026 showed 2.27 lakh shares delivered, representing 68.86% of that day’s traded volume. The same report recorded 39,779 trades.
The stock moved lower alongside broader sector weakness in Nifty Pharma while extending a recent multi-day pullback. With light trading volumes and no new same-day operational catalyst, the decline reflects ongoing sector pressure and technical consolidation.
Latest Company Developments
Mankind Pharma Limited submitted the scrutinizer's report of the postal ballot along with the formal voting results to the stock exchanges. This regulatory filing completes the procedural requirements associated with recent shareholder resolutions. The submission forms part of the standard corporate governance disclosure process.
It ensures transparency on shareholder voting outcomes regarding corporate resolutions.
The board of directors approved the integration of Bharat Serums and Vaccines Limited, a wholly owned material subsidiary, into the company through a process of voluntary liquidation. This strategic restructuring aims to streamline group operations and consolidate business units under the primary entity. Subsequent filings confirmed the related realignment of security cover and release of pledged shares.
Consolidating material subsidiaries can alter group corporate structure and operational efficiency over time.
Mankind Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Resignation of Statutory Auditors of a material wholly owned subsidiary company.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 10.87% on 30 June 2026. This compares with 10.36% on 31 March 2026, a change of +0.51 percentage points.
The filing reported 36 MF/UTI holders.
What to Watch Next
- Execution progress regarding the voluntary liquidation and integration of Bharat Serums and Vaccines Limited
- Upcoming quarterly financial results and management commentary on operational margins
- Delivery volumes relative to the 20-day average volume benchmark in subsequent sessions
- Sector performance trends within the Nifty Pharma index
Other Dated Coverage
- Why Mankind Pharma Shares Fell 2.21% Today: Sector Weakness & Context | 5 October 2026 — 5 October 2026
- Why Mankind Pharma Shares Are Down 2.36% Today | 1 October 2026 — 1 October 2026
- Why Mankind Pharma Shares Fell 1.62% Today: Sector Trends | 30 September 2026 — 30 September 2026
More Mankind Pharma news and dated analysis →
Frequently Asked Questions
What is the latest Mankind Pharma company news?
Mankind Pharma Limited submitted the scrutinizer's report of the postal ballot along with the formal voting results to the stock exchanges. This regulatory filing completes the procedural requirements associated with recent shareholder resolutions. The submission forms part of the standard corporate governance disclosure process.
How strong was Mankind Pharma’s trading volume?
28,828 shares traded, 0.05 times the 20-day average daily volume. The price and volume data are dated 14 October 2026 · 09:45 AM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 June 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.